BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29992402)

  • 1. [Normal tissue: radiosensitivity, toxicity, consequences for planning].
    Rühle A; Huber PE
    Radiologe; 2018 Aug; 58(8):746-753. PubMed ID: 29992402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study.
    Vandevoorde C; Depuydt J; Veldeman L; De Neve W; Sebastià N; Wieme G; Baert A; De Langhe S; Philippé J; Thierens H; Vral A
    Int J Radiat Biol; 2016 Dec; 92(12):823-836. PubMed ID: 27586010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants of radiosensitivity in normal and tumor tissue: A bioinformatic approach.
    Pavlopoulou A; Bagos PG; Koutsandrea V; Georgakilas AG
    Cancer Lett; 2017 Sep; 403():37-47. PubMed ID: 28619524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between normal tissue complications and in vitro radiosensitivity of skin fibroblasts derived from radiotherapy patients treated for variety of tumors.
    Alsbeih G; Malone S; Lochrin C; Girard A; Fertil B; Raaphorst GP
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):143-52. PubMed ID: 10656386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual Response to Ionizing Radiation and Personalized Radiotherapy.
    Domina EA; Philchenkov A; Dubrovska A
    Crit Rev Oncog; 2018; 23(1-2):69-92. PubMed ID: 29953368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation therapy tolerance limits. For one or for all?--Janeway Lecture.
    Peters LJ
    Cancer; 1996 Jun; 77(11):2379-85. PubMed ID: 8635110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical radiation pathology as applied to curative radiotherapy.
    Rubin P; Casarett GW
    Cancer; 1968 Oct; 22(4):767-78. PubMed ID: 5212301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention.
    Kerns SL; Kundu S; Oh JH; Singhal SK; Janelsins M; Travis LB; Deasy JO; Janssens AC; Ostrer H; Parliament M; Usmani N; Rosenstein BS
    Semin Radiat Oncol; 2015 Oct; 25(4):281-91. PubMed ID: 26384276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of radiation therapy on healthy tissues.
    Chargari C; Rassy E; Helissey C; Achkar S; Francois S; Deutsch E
    Int Rev Cell Mol Biol; 2023; 376():69-98. PubMed ID: 36997270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of radiation-induced late effects: What's new?].
    Chargari C; Supiot S; Hennequin C; Chapel A; Simon JM
    Cancer Radiother; 2020 Oct; 24(6-7):602-611. PubMed ID: 32855027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of radiation exposure: can they predict normal tissue radiosensitivity?
    Chua ML; Rothkamm K
    Clin Oncol (R Coll Radiol); 2013 Oct; 25(10):610-6. PubMed ID: 23870757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Normal tissue tolerance to external beam radiation therapy: rectum].
    Blanchard P; Chapet O
    Cancer Radiother; 2010 Jul; 14(4-5):354-8. PubMed ID: 20570201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T lymphocytes to predict radiation-induced late effects in normal tissues.
    Brengues M; Lapierre A; Bourgier C; Pèlegrin A; Özsahin M; Azria D
    Expert Rev Mol Diagn; 2017 Feb; 17(2):119-127. PubMed ID: 27936985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes.
    López E; Guerrero R; Núñez MI; del Moral R; Villalobos M; Martínez-Galán J; Valenzuela MT; Muñoz-Gámez JA; Oliver FJ; Martín-Oliva D; Ruiz de Almodóvar JM
    Breast Cancer Res; 2005; 7(5):R690-8. PubMed ID: 16168114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late side-effects after curative intent radiotherapy: Identification of hypersensitive patients for personalized strategy.
    Bourgier C; Lacombe J; Solassol J; Mange A; Pèlegrin A; Ozsahin M; Azria D
    Crit Rev Oncol Hematol; 2015 Mar; 93(3):312-9. PubMed ID: 25497158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in normal tissue toxicity induced by ionizing radiation.
    Popanda O; Marquardt JU; Chang-Claude J; Schmezer P
    Mutat Res; 2009 Jul; 667(1-2):58-69. PubMed ID: 19022265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and late radiation-induced skin alterations. Part I: Mechanisms of skin changes.
    Sitton E
    Oncol Nurs Forum; 1992 Jun; 19(5):801-7. PubMed ID: 1608843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responses of normal cells to ionizing radiation.
    Rodemann HP; Blaese MA
    Semin Radiat Oncol; 2007 Apr; 17(2):81-8. PubMed ID: 17395038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionizing radiation-induced cellular senescence promotes tissue fibrosis after radiotherapy. A review.
    Nguyen HQ; To NH; Zadigue P; Kerbrat S; De La Taille A; Le Gouvello S; Belkacemi Y
    Crit Rev Oncol Hematol; 2018 Sep; 129():13-26. PubMed ID: 30097231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying patients at risk for late radiation-induced toxicity.
    Azria D; Betz M; Bourgier C; Jeanneret Sozzi W; Ozsahin M
    Crit Rev Oncol Hematol; 2012 Dec; 84 Suppl 1():e35-41. PubMed ID: 20869261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.